In the last two decades, following the description of the structure of the human genome, gender-specific medicine is evolving in precise and exciting detail at the molecular level. Gender and the Genome specifically aims to publish new findings about the molecular biology that will eventually underlie at least the best approximation we can offer of personalized, gender-specific medicine.

The journal is open access, fully peer-reviewed, and the official journal of The Foundation for Gender-Specific Medicine. We are soliciting basic research at the molecular level that expands our understanding of the physiological and environmental components that shape the individual.

Gender and the Genome’s mission is to a resource for molecular biologists, clinicians and physicians, the legal and ethical community, sociologists and epidemiologists, and the young, untenured scientist engaged in gender-specific medicine. It is our hope that as our skills at defining molecular biology expand, our audience will deploy this new biology ever more effectively to maintain health, prevent disease, and treat the sick patient. Bringing molecular genetic mechanisms to the bedside is our ultimate goal.

The journal currently accepts original research, reviews, brief communications, commentaries, and letters to the editor. Topics of interest include, but are not limited to:

  • Legal and ethical views on significant therapeutic proposals or interventions
  • The importance of the environment in human variability from a sociological and epidemiological point of view
  • Identification of specific elements in gene regulation
  • Impact of biological sex on gene expression
  • Mechanisms by which environmental experience impact gene regulation
  • Transmission of epigenetic features of the genome to subsequent generations
  • Insight into whether gene mutation or epigenetic modification create an observed departure from normal physiology
  • How genetic or epigenetic manipulation can be translated into patient care